Dacoplice 30mg Tablet
Marketer
Pfizer Ltd
Salt Composition
Dacomitinib (30mg)
Overview Dacoplice 30mg Tablet
Dacoplice 30mg tablets are indicated for non-small cell lung cancer therapy. Its mechanism of action involves inhibiting or retarding cancerous cell proliferation. A patient support/assistance program, administered by Tata 1mg, exists in India for this medication. Consult your physician for program enrollment information, or dial (1800-102-1618) for further details.
Uses of Dacoplice 30mg Tablet
Managing Non-small Cell Lung Carcinoma
Major Benefits of Dacoplice 30mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Dacoplice 30mg Tablets can be consumed with or without food, however, consistent timing is recommended for optimal results.
Common Side effects of Dacoplice 30mg Tablet:
- Constipation
- Stomatitis (Inflammation of the mouth)
- Rash
- Diarrhea
- Weight loss
- Cough
- Low albumin level in blood
- Paronychia
- Increased glucose level in blood
- Decreased calcium level in blood
- Increased liver enzymes
- Dry skin
- Decreased appetite
- Lymphopenia
How to use Dacoplice 30mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 30mg Dacoplice tablet whole; do not alter its form. While you can take it with or without food, consistency in timing is recommended.
How Dacoplice 30mg Tablet works:
Dacoplice 30mg tablets target the human epidermal growth factor receptor (HER) protein, a factor potentially accelerating cancer cell growth and metastasis. This targeted action may help control cancer progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Dacoplice 30mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Dacoplice 30mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Dacoplice 30mg tablets while breastfeeding is likely inadvisable. Available evidence from humans indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
Driving ability while taking Dacoplice 30mg Tablet is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Renal impairment does not necessitate a dosage alteration for Dacoplice 30mg tablets, which are considered safe for use in such patients.
LiverSAFE IF PRESCRIBED
Patients with liver impairment may safely use Dacoplice 30mg tablets without requiring a dosage modification.
What if you forget to take Dacoplice 30mg Tablet :
NA
Facts to Know About Dacoplice 30mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Quinazoline derivative |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently